TP53 and colorectal carcinoma: Therefore, this study investigated whether TP53 polymorphisms are associated with CRC risk in patients with Lynch syndrome and whether TP53 polymorphisms interact with lifestyle factors and modify CRC risk in patients with Lynch syndrome.